Patents by Inventor Anette Mullertz

Anette Mullertz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • A FLEXIBLE FOIL FOR THE DELIVERY OF THERAPEUTIC CARGOS
    Publication number: 20240000708
    Abstract: The present invention relates to a drug delivery platform. In particular, it relates to a foil-based drug delivery platform for delivery to the intestine.
    Type: Application
    Filed: March 31, 2021
    Publication date: January 4, 2024
    Inventors: Anja Boisen, Lasse Hølund Eklund Thamdrup, Jacob Rune Jørgensen, Thomas Rades, Anette Müllertz, Mahdi Ghavami, Khorshid Kam Guyan
  • Compositions comprising a fatty aged oil mixture and a free fatty acid, and methods and uses thereof
    Patent number: 11523999
    Abstract: Compositions comprising a fatty acid oil mixture and at least one free fatty acid, and uses thereof are disclosed. Further disclosed are preconcentrates capable of forming a self-nanoemulsifying drug delivery system (SNEDDS), a self-microemulsifying drug delivery system (SMEDDS) or self-emulsifying drug delivery systems (SEDDS) in an aqueous solution. Preferred fatty acids are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in a form chosen from ethyl ester and triglyceride.
    Type: Grant
    Filed: March 24, 2020
    Date of Patent: December 13, 2022
    Assignee: PRONOVA BIOPHARMA NORGE AS
    Inventors: Svein Olaf Hustvedt, Preben Houlberg Olesen, Gunnar Berge, Anette Mullertz
  • A CELLULAR SOLID MATERIAL DRUG CARRIER COMPRISING CELLULOSE NANOFIBERS (CNF) WHEREIN THE CELLULAR SOLID MATERIAL COMPRISES CLOSED CELLS
    Publication number: 20210283260
    Abstract: The present invention relates to a structure for the controlled release of at least one active substance, where the structure comprises the active substance and a cellular solid material comprising cellulose nanofibers (CNF). The structure has a density of less than 1000 kg/m3, and the cellular solid material comprises closed cells. The invention further relates to a method for preparing the structure; as well as the use of the structure.
    Type: Application
    Filed: July 7, 2017
    Publication date: September 16, 2021
    Inventors: Anna Justina Hanner, Korbinian Löbmann, Anette Müllertz, Daniel Bar-Shalom, Lars-Erik Wågberg
  • COMPOSITIONS COMPRISING A FATTY ACID OIL MIXTURE AND A FREE FATTY ACID, AND METHODS AND USES THEREOF
    Publication number: 20210085632
    Abstract: Compositions comprising a fatty acid oil mixture and at least one free fatty acid, and uses thereof are disclosed. Further disclosed are preconcentrates capable of forming a self-nanoemulsifying drug delivery system (SNEDDS), a self-microemulsifying drug delivery system (SMEDDS) or self-emulsifying drug delivery systems (SEDDS) in an aqueous solution. Preferred fatty acids are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in a form chosen from ethyl ester and triglyceride.
    Type: Application
    Filed: March 24, 2020
    Publication date: March 25, 2021
    Inventors: Svein Olaf HUSTVEDT, Preben Houlberg OLESEN, Gunnar BERGE, Anette MULLERTZ
  • Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof
    Patent number: 10596142
    Abstract: Compositions comprising a fatty acid oil mixture and at least one free fatty acid, and uses thereof are disclosed. Further disclosed are preconcentrates capable of forming a self- nanoemulsifying drug delivery system (SNEDDS), a self-microemulsifying drug delivery system (SMEDDS) or self-emulsifying drug delivery systems (SEDDS) in an aqueous solution. Preferred fatty acids are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in a form chosen from ethyl ester and triglyceride.
    Type: Grant
    Filed: July 23, 2018
    Date of Patent: March 24, 2020
    Assignee: Pronova Biopharm Norge AS
    Inventors: Svein Olaf Hustvedt, Preben Houlberg Olesen, Gunnar Berge, Anette Mullertz
  • EDIBLE SEMI-SOLID COMPOSITION FOR USE IN PATIENTS UNDERGOING ENDOSCOPY INCLUDING COLONOSCOPY
    Publication number: 20190298757
    Abstract: The present invention relates to a GI-cleansing composition comprising i) one or more gelling or swelling agents, ii) one or more laxative agents, iii) one of more taste-improving agents, and iv) water.
    Type: Application
    Filed: May 5, 2017
    Publication date: October 3, 2019
    Applicants: UNIVERSITY OF COPENHAGEN, SJÆLLANDS UNIVERSITETSHOSPITAL
    Inventors: Daniel BAR-SHALOM, Peter VILMANN, Anette MÜLLERTZ, Jacob Kolstrup ZEDERKOF, Hanne HOLM, Jette JACOBSEN
  • COMPOSITIONS COMPRISING A FATTY ACID OIL MIXTURE AND A FREE FATTY ACID, AND METHODS AND USES THEREOF
    Publication number: 20190183838
    Abstract: Compositions comprising a fatty acid oil mixture and at least one free fatty acid, and uses thereof are disclosed. Further disclosed are preconcentrates capable of forming a self- nanoemulsifying drug delivery system (SNEDDS), a self-microemulsifying drug delivery system (SMEDDS) or self-emulsifying drug delivery systems (SEDDS) in an aqueous solution. Preferred fatty acids are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in a form chosen from ethyl ester and triglyceride.
    Type: Application
    Filed: July 23, 2018
    Publication date: June 20, 2019
    Inventors: Svein Olaf HUSTVEDT, Preben Houlberg OLESEN, Gunnar BERGE, Anette MULLERTZ
  • Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof
    Patent number: 10028928
    Abstract: Compositions comprising a fatty acid oil mixture and at least one free fatty acid, and uses thereof are disclosed. Further disclosed are preconcentrates capable of forming a self-nanoemulsifying drug delivery system (SNEDDS), a self-microemulsifying drug delivery system (SMEDDS) or self-emulsifying drug delivery systems (SEDDS) in an aqueous solution. Preferred fatty acids are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in a form chosen from ethyl ester and triglyceride.
    Type: Grant
    Filed: November 14, 2016
    Date of Patent: July 24, 2018
    Assignee: Pronova Biopharma Norge AS
    Inventors: Svein Olaf Hustvedt, Preben Houlberg Olesen, Gunnar Berge, Anette Mullertz
  • COMPOSITIONS COMPRISING A FATTY ACID OIL MIXTURE AND A FREE FATTY ACID, AND METHODS AND USES THEREOF
    Publication number: 20170112795
    Abstract: Compositions comprising a fatty acid oil mixture and at least one free fatty acid, and uses thereof are disclosed. Further disclosed are preconcentrates capable of forming a self-nanoemulsifying drug delivery system (SNEDDS), a self-microemulsifying drug delivery system (SMEDDS) or self-emulsifying drug delivery systems (SEDDS) in an aqueous solution. Preferred fatty acids are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in a form chosen from ethyl ester and triglyceride.
    Type: Application
    Filed: November 14, 2016
    Publication date: April 27, 2017
    Inventors: Svein Olaf HUSTVEDT, Preben Houlberg OLESEN, Gunnar BERGE, Anette MULLERTZ
  • Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof
    Patent number: 9532963
    Abstract: Compositions comprising a fatty acid oil mixture and at least one free fatty acid, and uses thereof are disclosed. Further disclosed are preconcentrates capable of forming a self-nanoemulsifying drug delivery system (SNEDDS), a self-microemulsifying drug delivery system (SMEDDS) or self-emulsifying drug delivery systems (SEDDS) in an aqueous solution. Preferred fatty acids are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in a form chosen from ethyl ester and triglyceride.
    Type: Grant
    Filed: March 9, 2010
    Date of Patent: January 3, 2017
    Assignee: Pronova Biopharma Norge AS
    Inventors: Svein Olaf Hustvedt, Preben Houlberg Olesen, Gunnar Berge, Anette Müllertz
  • Coated capsules and tablets of a fatty acid oil mixture
    Patent number: 9370493
    Abstract: Compositions comprising a fatty acid oil mixture and at least one free fatty acid in a coated capsule or a coated tablet form suitable for oral administration, and methods of use thereof, are disclosed. Further disclosed are preconcentrates comprising a fatty acid oil mixture, at least one surfactant, and optionally at least one free fatty acid, in a coated capsule or a coated tablet form, and methods of use thereof. The preconcentrates are capable of forming a self-nanoemulsifying drug delivery system (SNEDDS), a self-microemulsifying drug delivery system (SMEDDS), or self-emulsifying drug delivery systems (SEDDS) in an aqueous solution.
    Type: Grant
    Filed: October 22, 2010
    Date of Patent: June 21, 2016
    Assignee: Pronova Biopharma Norge AS
    Inventors: Jo Erik Johnsrud Klaveness, Gunnar Berge, Svein Olaf Hustvedt, Preben Houlberg Olesen, Anette Müllertz
  • COMPOSITIONS COMPRISING A FATTY ACID OIL MIXTURE, A FREE FATTY ACID, AND A STATIN
    Publication number: 20140017308
    Abstract: Compositions comprising a fatty acid oil mixture, at least one free fatty acid, and at least one statin or pharmaceutically acceptable salt, hydrate, solvate, or complex thereof, and uses thereof are disclosed. Further disclosed are preconcentrates capable of forming a self-nanoemulsifying drug delivery system (SNEDDS), a self-microemulsifying drug delivery system (SMEDDS), or self-emulsifying drug delivery systems (SEDDS) in an aqueous solution.
    Type: Application
    Filed: September 8, 2011
    Publication date: January 16, 2014
    Applicant: Pronova Biopharma Norge AS
    Inventors: Svein Olaf Hustvedt, Gunnar Berge, Preben Houlberg Olesen, Anette Müllertz
  • COMPOSITIONS COMPRISING A FATTY ACID OIL MIXTURE AND A FREE FATTY ACID, AND METHODS AND USES THEREOF
    Publication number: 20120232141
    Abstract: Compositions comprising a fatty acid oil mixture and at least one free fatty acid, and uses thereof are disclosed. Further disclosed are preconcentrates capable of forming a self-nanoemulsifying drug delivery system (SNEDDS), a self-microemulsifying drug delivery system (SMEDDS) or self-emulsifying drug delivery systems (SEDDS) in an aqueous solution. Preferred fatty acids are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in a form chosen from ethyl ester and triglyceride.
    Type: Application
    Filed: March 9, 2010
    Publication date: September 13, 2012
    Inventors: Svein Olaf Hustvedt, Preben Houlberg Olesen, Gunnar Berge, Anette Müllertz
  • Animal feed additives
    Patent number: 7217433
    Abstract: The present invention relates to animal feed additives, which additives comprise a monocomponent xylanase derived from a strain of Byssochlamus, Chaetomium, Humicola, Malbranchea, Mucor, Myceliophthora, Paecilomyces, Talaromyces, Thermoascus, or Thielavia. In other aspects, the invention relates to monocomponent xylanase preparations, DNA constructs, recombinant expression vectors, host cells, and methods of producing monocomponent xylanase preparations.
    Type: Grant
    Filed: December 20, 1999
    Date of Patent: May 15, 2007
    Assignee: Novozymes A/S
    Inventors: Peter Kamp Hansen, Peter Wagner, Anette Mullertz, Inge Helmer Knap
  • Enzyme with galactanase activity
    Patent number: 6485954
    Abstract: The present invention relates to an enzyme with galactanase activity, a DNA construct encoding the enzyme with galactanase activity, a method of producing the enzyme, an enzyme composition comprising said enzyme with galactanase activity, and the use of said enzyme and enzyme composition for a number of industrial applications.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: November 26, 2002
    Assignee: Novozymes A/S
    Inventors: Lene Venke Kofod, Markus Sakari Kauppinen, Lene Nonboe Andersen, Ib Groth Clausen, Anette Müllertz
  • ANIMAL FEED ADDITIVES
    Publication number: 20020160080
    Abstract: The present invention relates to animal feed additives, which additives comprise a monocomponent xylanase derived from a strain of Byssochlamus, Chaetomium, Humicola, Malbranchea, Mucor, Myceliophthora, Paecilomyces, Talaromyces, Thermoascus, or Thielavia. In other aspects, the invention relates to monocomponent xylanase preparations, DNA constructs, recombinant expression vectors, host cells, and methods of producing monocomponent xylanase preparations.
    Type: Application
    Filed: December 20, 1999
    Publication date: October 31, 2002
    Applicant: NOVOZYMES A/S KROGSHOEJVEJ 36 DK-2880 BAGSVAERD
    Inventors: PETER KAMP HANSEN, PETER WAGNER, ANETTE MULLERTZ, INGE HELMER KNAP
  • Animal feed additives
    Patent number: 6264946
    Abstract: The present invention relates to the combined use, simultaneous or sequential, of one or more xylanolytic enzymes of Type I with one or more xylanolytic enzymes of Type II in animal feed. It also relates to animal feed and animal feed additives comprising such combination of xylanolytic enzymes.
    Type: Grant
    Filed: October 9, 1998
    Date of Patent: July 24, 2001
    Assignee: Novozymes A/S
    Inventors: Anette Müllertz, Lene Beck Jensen, Betina Kastbjerg Jensen
  • Animal feed additives
    Patent number: 6245546
    Abstract: The present invention relates to animal feed additives, which additives comprise a monocomponent xylanase derived from a strain of Byssochlamus, Chaetomium, Humicola, Malbranchea, Mucor, Myceliophthora, Paecilomyces, Talaromyces, Thermoascus, or Thielavia. In other aspects, the invention relates to monocomponent xylanase preparations, DNA constructs, recombinant expression vectors, host cells, and methods of producing monocomponent xylanase preparations.
    Type: Grant
    Filed: July 15, 1998
    Date of Patent: June 12, 2001
    Assignee: Novo Nordisk A/S
    Inventors: Peter Kamp Hansen, Peter Wagner, Anette Mullertz, Inge Helmer Knap
  • Enzyme with galactanase activity
    Patent number: 6242237
    Abstract: The present invention relates to an enzyme with galactanase activity, a DNA construct encoding the enzyme with galactanase activity, a method of producing the enzyme, an enzyme composition comprising the enzyme with galactanase activity, and the use of the galactanase enzyme and enzyme composition for a number of industrial applications.
    Type: Grant
    Filed: August 21, 1998
    Date of Patent: June 5, 2001
    Assignee: Novo Nordisk A/S
    Inventors: Lene Venke Kofod, Markus Sakari Kauppinen, Lene Nonboe Andersen, Ib Groth Clausen, Anette Müllertz
  • Enzymes with xylanase activity from aspergillus aculeatus
    Patent number: 6228630
    Abstract: An enzyme preparation comprising (a) first enzyme with xylanase activity and (b) a second enzyme having cellulotytic, xylanolytic or pectinolytic activity and are supported by the specification.
    Type: Grant
    Filed: June 22, 2000
    Date of Patent: May 8, 2001
    Assignee: Novo Nordisk A/S
    Inventors: Lene Venke Kofod, MArkus Sakari Kauppinen, Stephan Christgau, Hans Peter Heldt-Hansen, Henrik Dalbøge, Lene Nonboe Andersen, Joan Qi Si, Tina Sejersgåard Jacobsen, Niels Munk, Anette Müllertz